Pyrazinamide together with oxytetracycline in patients with tubercle bacilli resistant to streptomycin, PAS and isoniazid.
D010131:Aminosalicylic Acid / Q000627:therapeutic use*; D001407:Bacillus; D007538:Isoniazid / Q000627:therapeutic use*; D007780:Lacticaseibacillus casei; D009525:Niacin / Q000031:analogs & derivatives; D009539:Nicotinic Acids; D010118:Oxytetracycline / Q000627:therapeutic use*; D011718:Pyrazinamide; D013307:Streptomycin / Q000627:therapeutic use*; D014376:Tuberculosis; D014397:Tuberculosis, Pulmonary / Q000628:therapy*
D009539:Nicotinic Acids; D009525:Niacin; D011718:Pyrazinamide; D010131:Aminosalicylic Acid; D007538:Isoniazid; D010118:Oxytetracycline; D013307:Streptomycin
ISONIAZID/therapeutic use; NICOTINIC ACID/related compounds; OXYTETRACYCLINE/therapeutic use; PARA-AMINOSALICYLIC ACID/therapeutic use; STREPTOMYCIN/therapeutic use; TUBERCULOSIS, PULMONARY/therapy